Day One Biopharmaceuticals (DAWN)
US Market

Day One Biopharmaceuticals (DAWN) Stock Price & Analysis


DAWN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$9.67 - $25.77
Previous Close$12.26
Average Volume (3M)839.92K
Market Cap
Enterprise Value$662.12M
Total Cash (Recent Filing)$405.54M
Total Debt (Recent Filing)$514.00K
Price to Earnings (P/E)-5.4
Mar 04, 2024
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.28
Shares Outstanding87,042,933
10 Day Avg. Volume487,088
30 Day Avg. Volume839,923
Standard Deviation0.38
Financial Highlights & Ratios
Price to Book (P/B)2.74
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-7.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue181.45
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-5.22
Price Target Upside196.05% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8



Ownership Overview

19.12% Mutual Funds
60.19% Other Institutional Investors
20.69% Public Companies and
Individual Investors


What was Day One Biopharmaceuticals’s price range in the past 12 months?
Day One Biopharmaceuticals lowest stock price was $9.67 and its highest was $25.77 in the past 12 months.
    What is Day One Biopharmaceuticals’s market cap?
    Currently, no data Available
    When is Day One Biopharmaceuticals’s upcoming earnings report date?
    Day One Biopharmaceuticals’s upcoming earnings report date is Mar 04, 2024 which is in 90 days.
      How were Day One Biopharmaceuticals’s earnings last quarter?
      Day One Biopharmaceuticals released its earnings results on Nov 06, 2023. The company reported -$0.54 earnings per share for the quarter, beating the consensus estimate of -$0.586 by $0.046.
        Is Day One Biopharmaceuticals overvalued?
        According to Wall Street analysts Day One Biopharmaceuticals’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Day One Biopharmaceuticals pay dividends?
          Day One Biopharmaceuticals does not currently pay dividends.
          What is Day One Biopharmaceuticals’s EPS estimate?
          Day One Biopharmaceuticals’s EPS estimate is -$0.57.
            How many shares outstanding does Day One Biopharmaceuticals have?
            Day One Biopharmaceuticals has 87,042,930 shares outstanding.
              What happened to Day One Biopharmaceuticals’s price movement after its last earnings report?
              Day One Biopharmaceuticals reported an EPS of -$0.54 in its last earnings report, beating expectations of -$0.586. Following the earnings report the stock price went up 1.395%.
                Which hedge fund is a major shareholder of Day One Biopharmaceuticals?
                Among the largest hedge funds holding Day One Biopharmaceuticals’s share is RA Capital Management. It holds Day One Biopharmaceuticals’s shares valued at 96M.


                  Company Description

                  Day One Biopharmaceuticals

                  Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The lead product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.


                  Top 5 ETFs holding DAWN

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Vanguard Health Care ETF
                  Fidelity Nasdaq Composite Index ETF
                  Schwab U.S. Broad Market ETF
                  Vanguard Russell 3000 ETF
                  Up to five ETFs with an Outperform Smart Score that hold DAWN. The ETFs are listed according to market value of DAWN within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  BioNTech SE
                  Arvinas Holding Company
                  Editas Medicine

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis